title: Levodopa-carbidopa treatment and falsely high urinary dopamine levels.
authors.forename: Sruti
authors.initials: S
authors.lastname: Chandrasekaran
authors.forename: Nicoleta
authors.initials: N
authors.lastname: Ionica
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Streeten
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000601:surgery; D000315:Adrenalectomy / Q000009:adverse effects; D000368:Aged; D002230:Carbidopa / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004298:Dopamine / Q000378:metabolism / Q000652:urine*; D004338:Drug Combinations; D016903:Drug Monitoring; D006801:Humans; D007414:Intestinal Neoplasms / Q000378:metabolism / Q000556:secondary; D007980:Levodopa / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008297:Male; D010302:Parkinson Disease, Secondary / Q000188:drug therapy* / Q000209:etiology / Q000652:urine; D010673:Pheochromocytoma / Q000378:metabolism / Q000556:secondary / Q000601:surgery
chemical_list: D004338:Drug Combinations; C009265:carbidopa, levodopa drug combination; D007980:Levodopa; D002230:Carbidopa; D004298:Dopamine